1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GILEAD SCIENCES, INC.
Gilead Sciences, Inc. XNAS: GILD

Gilead Sciences Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Soval...

Read More
123.24 1.90 (1.57%)
Near 52W High of $128.70
1.7M
XNAS Volume

XNAS 11 Dec, 2025 12:12 PM (EST)

Watchlist

Portfolio

Alert
Dividend
Gilead Sciences has an upcoming dividend of $0.79 per share due on 15 Dec 2025 See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Affordable Valuation
58.8 / 100
Momentum Score
Technically Neutral
51.6 / 100
Mid-range Performer These stocks may be affordable or expensive, based on their medium quality and mid-range technical score. However, their reasonable financials are successful in gathering some investor interest. View Similar Embed DVM
Analyst Price Target
132
1Yr Price target upside is 7%
26 analysts

16

S

5

W

4

O

0

T

SWOT Analysis

Gilead Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..